This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. (ABBV) rose 1.05% to $225.42 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.17% to 50,872.11 and the S&amp;P 500 Index falling 0.26% to 7,386.65.
AbbVie Inc. closed 7.92% below its 52-week high of $244.81, which the company achieved on October 1st.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson &amp; Johnson (JNJ) rose 2.08% to $237.00, Pfizer Inc. (PFE) rose 0.31% to $25.70, and Amgen Inc. (AMGN) fell 0.34% to $344.57.
Trading volume (4.1 M) remained 2.2 million below its 50-day average volume of 6.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 9, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
06-09-26 1631ET

ABBV

AbbVie Inc. (ABBV) shares rose 1.05% to $225.42 on Tuesday, underperforming competitors like Johnson & Johnson and Pfizer despite the daily gain. The stock closed 7.92% below its 52-week high of $244.81. Trading volume was lower than the 50-day average.

MarketWatch Automated

Abbvie

Dow Jones Industrial Average

AbbVie Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains